Prenetics Group Limited (PRE): Price and Financial Metrics
PRE Price/Volume Stats
| Current price | $8.21 | 52-week high | $11.99 |
| Prev. close | $9.00 | 52-week low | $3.09 |
| Day low | $8.15 | Volume | 27,900 |
| Day high | $9.51 | Avg. volume | 17,925 |
| 50-day MA | $5.73 | Dividend yield | N/A |
| 200-day MA | $5.13 | Market Cap | 100.20M |
PRE Stock Price Chart Interactive Chart >
Prenetics Group Limited (PRE) Company Bio
Prenetics Group Limited operates as a diagnostics and genetic testing company worldwide. It develops consumer genetic testing and early colorectal cancer screening products; and provides COVID-19 testing, rapid point of care and at-home diagnostic testing, and medical genetic testing products. The company's products include CircleDNA, a consumer genetic testing offering that uses whole exome sequencing; Project Screen, a COVID-19 test; and Circle HealthPod, a molecular testing product for COVID-19. It is also developing ColoClear, a non-invasive stool-based FIT-DNA test for colorectal cancer screening; Circle SnapShot, an at-home blood test with a user-friendly blood sample collection and result delivery system; Circle Medical, a test to identify causal genetic mutations for patients; and Circle One and F1x/Fem, a DNA profile and questionnaire based personalized nutrition solution. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
PRE Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
PRE Price Returns
| 1-mo | 57.88% |
| 3-mo | 72.87% |
| 6-mo | 59.26% |
| 1-year | 41.55% |
| 3-year | -88.97% |
| 5-year | N/A |
| YTD | 41.55% |
| 2024 | -1.86% |
| 2023 | -80.30% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |